跳至主要内容
临床试验/NCT00276328
NCT00276328已完成4 期

Efficacy of Diosmectite (Smecta®) in the Treatment of Acute Diarrhoea in Adults. A Multicentre, Randomised, Double Blind, Placebo Controlled, Parallel Groups Study.

Ipsen62 个研究点 分布在 2 个国家目标入组 346 人开始时间: 2005年1月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Ipsen
入组人数
346
试验地点
62
主要终点
Time to recovery ie time (hours) from the first sachet intake to the first formed stool (this formed stool must have been followed by a non-watery stool)

研究概览

简要总结

The purpose of this study is to evaluate whether Smecta® is more effective than placebo with respect to time to recovery following an acute diarrhoea episode.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute diarrhoea episode defined as at least 3 watery stools per day for 48 hours or less
  • Patient with, usually, normal bowel habits, i.e. at least 3 stools per week and no more than 3 stools per day

排除标准

  • Gross blood, pus in the stools
  • Fever >39ºC
  • Other episode of acute watery diarrhoea within the last 30 days
  • History of chronic diarrhoea or motor diarrhoea

结局指标

主要结局

Time to recovery ie time (hours) from the first sachet intake to the first formed stool (this formed stool must have been followed by a non-watery stool)

次要结局

  • Number of stools and number of watery stools per 12 hour period
  • Global evaluation of efficacy by the patient at Day 4 and Day 8 visits by a mean Visual Analogue Scale (VAS)
  • Time (hours) from first sachet intake to the last watery stool
  • % of patients with recovery, per 12 hour period
  • % of patients with associated symptoms such as nausea, abdominal pain, anal irritation, per 12 hour period

研究者

发起方
Ipsen
申办方类型
Industry
责任方
Sponsor

研究点 (62)

Loading locations...

相似试验